Biohaven (BHVN) Non-Current Assets (2021 - 2026)

Biohaven's (BHVN) quarterly Non-Current Assets came in at $80.8 million in Q1 2026, up 6.0% year-on-year from $76.2 million in Q1 2025, and down 2.84% quarter-over-quarter from $83.1 million in Q4 2025.

Biohaven (BHVN) Non-Current Assets (2021 - 2026) Analysis & Trends

Biohaven has disclosed Non-Current Assets across 6 years of filings, most recently posting $80.8 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $80.8 million, up 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.0 million (up 10.45% YoY), and the FY2025 annual result was $83.1 million, up 8.46% from the prior year.
  • Non-Current Assets came in at $80.8 million for Q1 2026 at Biohaven, down from $83.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $85.5 million in Q3 2025 to a low of $55.1 million in Q3 2022.
  • The 5-year median for Non-Current Assets is $74.0 million (2023), against an average of $73.9 million.
  • Across the five-year window, Non-Current Assets soared 58.38% in 2022 and slipped 5.75% in 2024, its largest moves.
  • Biohaven's Non-Current Assets stood at $74.8 million in 2022, then dropped by 5.41% to $70.8 million in 2023, then grew by 8.29% to $76.6 million in 2024, then rose by 8.46% to $83.1 million in 2025, then dropped by 2.84% to $80.8 million in 2026.
  • The last three Non-Current Assets figures came in at $80.8 million (Q1 2026), $83.1 million (Q4 2025), and $85.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Biohaven 1.62 Bn 1.27 Bn - 80.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.76 Mn
Dec 31, 2025 83.12 Mn
Sep 30, 2025 85.51 Mn
Jun 30, 2025 75.59 Mn
Mar 31, 2025 76.19 Mn
Dec 31, 2024 76.64 Mn
Sep 30, 2024 70.02 Mn
Jun 30, 2024 71.37 Mn
Mar 31, 2024 69.79 Mn
Dec 31, 2023 70.77 Mn
Sep 30, 2023 72.17 Mn
Jun 30, 2023 72.62 Mn
Mar 31, 2023 74.05 Mn
Dec 31, 2022 74.82 Mn
Sep 30, 2022 55.10 Mn
Dec 31, 2021 47.24 Mn